{
  "case_id": "Case005_11",
  "ranked_differential_diagnosis": [
    {
      "rank": 1,
      "label": "Ototoxicity (Amikacin-induced)",
      "rationale_short": "Significant bilateral threshold shifts in high and ultra-high frequencies compared to baseline, coinciding with high-dose amikacin treatment."
    }
  ],
  "investigations_and_interpretations": {
    "ordered_list": [
      {
        "action": "Pure-tone audiometry",
        "urgency": "routine",
        "rationale_short": "Monitor standard frequency thresholds (250-8000 Hz) for changes compared to baseline."
      },
      {
        "action": "High-frequency audiometry",
        "urgency": "routine",
        "rationale_short": "Monitor ultra-high frequencies (9000-20000 Hz), which are typically the first to show ototoxic damage."
      },
      {
        "action": "Speech audiometry",
        "urgency": "routine",
        "rationale_short": "Assess functional speech understanding capabilities."
      },
      {
        "action": "Tympanometry",
        "urgency": "routine",
        "rationale_short": "Evaluate middle ear status."
      },
      {
        "action": "Acoustic reflexes",
        "urgency": "routine",
        "rationale_short": "Assess retrocochlear function."
      }
    ],
    "expected_interpretations_by_visit": [
      {
        "visit_id": "V1",
        "collective_interpretation": "The patient exhibits normal hearing in the low-to-mid frequencies but significant bilateral sensorineural hearing loss in the high and ultra-high frequencies. Comparison with baseline reveals substantial threshold shifts consistent with amikacin ototoxicity. Speech recognition remains excellent in quiet.",
        "tests": [
          {
            "name": "Pure-tone audiometry",
            "category": "Audiometry",
            "result_summary": "Right ear normal 250-4000 Hz, sloping to moderate SNHL at 6000-8000 Hz. Left ear normal 250-6000 Hz, mild SNHL at 8000 Hz. Significant shifts from baseline: Right ear decreased 35 dB at 6000 Hz and 45 dB at 8000 Hz; Left ear decreased 40 dB at 8000 Hz."
          },
          {
            "name": "High-frequency audiometry",
            "category": "Audiometry",
            "result_summary": "Moderate to moderately severe loss 9000-14000 Hz bilaterally; no response 16000-20000 Hz. Significant shifts from baseline (e.g., 20-35 dB decreases across 9000-11200 Hz)."
          },
          {
            "name": "Speech audiometry",
            "category": "Speech",
            "result_summary": "SRT Right 2 dB HL, Left -2 dB HL. WRS Right 100%, Left 96% at 50 dB HL."
          },
          {
            "name": "Tympanometry",
            "category": "Immittance",
            "result_summary": "Normal Type A tympanograms bilaterally."
          },
          {
            "name": "Acoustic reflexes",
            "category": "Immittance",
            "result_summary": "Ipsilateral and contralateral thresholds WNL 500-4000 Hz, except Left contralateral elevated at 500 Hz. Reflex decay negative."
          }
        ]
      }
    ]
  },
  "treatment_and_management": {
    "proposed_items": [
      "Consult with prescribing physician to switch antibiotic",
      "Hearing protection"
    ],
    "counseling_actions": [
      "Discuss significant high-frequency hearing changes linked to medication",
      "Explain the need to coordinate with the physician for potential medication change",
      "Recommend hearing protection in loud environments"
    ]
  },
  "escalation_and_red_flags": {
    "red_flags_present": [],
    "escalation": {
      "urgency": "urgent",
      "destination": "Prescribing physician",
      "rationale_short": "Significant ototoxic threshold shift requires immediate medical review to consider alternative treatment and prevent further loss."
    }
  },
  "follow_up_plan": {
    "timeline": "1 month",
    "objective": "Monitor hearing stability following intervention."
  },
  "expected_outcome": [
    "Physicians switched the patient from amikacin to another antibiotic due to hearing loss and lack of lung infection improvement.",
    "Hearing was tested 1 month later and was stable.",
    "Hearing protection was recommended."
  ]
}